A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

NCT03283085 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
557
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shire